Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio (2012 - 2026)
Enanta Pharmaceuticals (ENTA) posted Interest Coverage Ratio of 1.54 for Q1 2026, up 57.78% on a QoQ basis from 3.65 in Q4 2025, and up 89.23% year-over-year from 0.81 in Q1 2025.
Enanta Pharmaceuticals (ENTA) Interest Coverage Ratio (2012 - 2026) Analysis & Trends
Enanta Pharmaceuticals' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 1.54 for Q1 2026.
- Quarterly Interest Coverage Ratio rose 89.23% year-over-year to 1.54 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.85 (down 206.9% YoY) and the FY2025 annual result came in at 0.6, up 94.23% from the prior year.
- Interest Coverage Ratio was 1.54 for Q1 2026 at Enanta Pharmaceuticals, up from 3.65 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 3103.0 in Q3 2023 and bottomed at 18.38 in Q2 2023.
- A 5-year average of 202.11 and a median of 1.7 in 2022 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio sank 6335.9% — and 2024, when it jumped 96.11%.
- Enanta Pharmaceuticals' Interest Coverage Ratio stood at 1.7 in 2022, then plunged by 496.15% to 10.14 in 2023, then gained by 22.8% to 7.83 in 2024, then jumped by 53.37% to 3.65 in 2025, then jumped by 57.78% to 1.54 in 2026.
- Business Quant data shows ENTA's Interest Coverage Ratio at 1.54 in Q1 2026, 3.65 in Q4 2025, and 1.97 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Enanta Pharmaceuticals | 376.07 Mn | 212.29 Mn | - | -1.54 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.54 |
| Dec 31, 2025 | -3.65 |
| Sep 30, 2025 | -1.97 |
| Jun 30, 2025 | -0.21 |
| Mar 31, 2025 | -14.31 |
| Dec 31, 2024 | -7.83 |
| Sep 30, 2024 | -9.18 |
| Jun 30, 2024 | -0.72 |
| Mar 31, 2024 | -1.03 |
| Dec 31, 2023 | -10.14 |
| Sep 30, 2023 | 3,103.00 |
| Jun 30, 2023 | -18.38 |
| Dec 31, 2022 | -1.70 |
| Jun 30, 2022 | -0.29 |
| Mar 31, 2022 | -0.41 |
| Dec 31, 2021 | -0.31 |
| Sep 30, 2021 | -1.15 |
| Jun 30, 2021 | -1.92 |
| Mar 31, 2021 | -1.01 |
| Dec 31, 2020 | -0.76 |